| Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes (NCT00982644) | Novo Nordisk A/S | 2009-09-01 |
| Investigation of the Response Relationship of NN5401 in Type 1 Diabetics (NCT00993096) | Novo Nordisk A/S | 2009-09-01 |
| Safety and Tolerability of NN9068 in Healthy Male Volunteers (NCT00983021) | Novo Nordisk A/S | 2009-09-01 |
| Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes (NCT00982228) | Novo Nordisk A/S | 2009-09-01 |
| Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes (NCT00972283) | Novo Nordisk A/S | 2009-09-01 |
| Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors (NCT00951405) | Novo Nordisk A/S | 2009-09-01 |
| Comparison of Two NN1250 Formulations in Healthy Volunteers (NCT00966368) | Novo Nordisk A/S | 2009-08-01 |
| A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver Function (NCT00976326) | Novo Nordisk A/S | 2009-08-01 |
| A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone (NCT00936403) | Novo Nordisk A/S | 2009-08-01 |
| Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes (NCT00978627) | Novo Nordisk A/S | 2009-08-01 |
| Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B (NCT00956345) | Novo Nordisk A/S | 2009-08-01 |
| Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers (NCT00959101) | Novo Nordisk A/S | 2009-08-01 |
| A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes (NCT00964418) | Novo Nordisk A/S | 2009-08-01 |
| A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics (NCT00964964) | Novo Nordisk A/S | 2009-08-01 |
| A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes (NCT00961324) | Novo Nordisk A/S | 2009-07-27 |
| An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin® (NCT00934063) | Novo Nordisk A/S | 2009-07-01 |
| Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery (NCT00914589) | Novo Nordisk A/S | 2009-07-01 |
| A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers (NCT00951873) | Novo Nordisk A/S | 2009-07-01 |
| A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects (NCT00897169) | Novo Nordisk A/S | 2009-06-01 |
| Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B (NCT00922792) | Novo Nordisk A/S | 2009-06-01 |
| Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia (NCT00842894) | Novo Nordisk A/S | 2009-05-01 |
| Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00909480) | Novo Nordisk A/S | 2009-05-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Malaysia (NCT00877526) | Novo Nordisk A/S | 2009-05-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan (NCT00887874) | Novo Nordisk A/S | 2009-05-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea (NCT00918151) | Novo Nordisk A/S | 2009-05-01 |
| Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment (NCT00795600) | Novo Nordisk A/S | 2009-04-01 |
| An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries (NCT00842192) | Novo Nordisk A/S | 2009-04-01 |
| Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients (NCT00834262) | Novo Nordisk A/S | 2009-04-01 |
| Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues (NCT00873639) | Novo Nordisk A/S | 2009-04-01 |
| Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects (NCT00840086) | Novo Nordisk A/S | 2009-04-01 |
| PROPACT: Retrospective Prophylaxis Patient Case Collection (NCT00882778) | Novo Nordisk A/S | 2009-04-01 |
| A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in Philippines (NCT00874159) | Novo Nordisk A/S | 2009-04-01 |
| Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects (NCT00837356) | Novo Nordisk A/S | 2009-03-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Bangladesh (NCT00839878) | Novo Nordisk A/S | 2009-03-01 |
| The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes (NCT00856986) | Novo Nordisk A/S | 2009-03-01 |
| Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir (NCT00873223) | Novo Nordisk A/S | 2009-03-01 |
| Effect of Renal Impairment on the Pharmacokinetics of NN9535 (NCT00833716) | Novo Nordisk A/S | 2009-02-02 |
| Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment (NCT00865397) | Novo Nordisk A/S | 2009-02-01 |
| Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects (NCT00851773) | Novo Nordisk A/S | 2009-02-01 |
| Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease (NCT00849316) | Novo Nordisk A/S | 2009-02-01 |
| Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects (NCT00787878) | Novo Nordisk A/S | 2009-02-01 |
| Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs (NCT00819741) | Novo Nordisk A/S | 2009-02-01 |
| Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes (NCT00841087) | Novo Nordisk A/S | 2009-01-01 |
| Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers (NCT00822185) | Novo Nordisk A/S | 2009-01-01 |
| Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir® (NCT00806897) | Novo Nordisk A/S | 2009-01-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Singapore (NCT00836030) | Novo Nordisk A/S | 2009-01-01 |
| Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus (NCT00842361) | Novo Nordisk A/S | 2009-01-01 |
| A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects (NCT00813020) | Novo Nordisk A/S | 2009-01-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand (NCT00805922) | Novo Nordisk A/S | 2008-12-01 |
| Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects (NCT00806936) | Novo Nordisk A/S | 2008-12-01 |
| Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes (NCT00807092) | Novo Nordisk A/S | 2008-12-01 |
| Observational Study on Levemir® in Obese Diabetic Patients (NCT00849342) | Novo Nordisk A/S | 2008-12-01 |
| Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis (NCT00818064) | Novo Nordisk A/S | 2008-12-01 |
| Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus (NCT00806858) | Novo Nordisk A/S | 2008-11-01 |
| Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication (NCT00869908) | Novo Nordisk A/S | 2008-11-01 |
| Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome (NCT00705172) | Novo Nordisk A/S | 2008-11-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia (NCT00788853) | Novo Nordisk A/S | 2008-11-01 |
| Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes. (NCT00793273) | Novo Nordisk A/S | 2008-11-01 |
| Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes (NCT00789191) | Novo Nordisk A/S | 2008-11-01 |
| An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes (NCT00789711) | Novo Nordisk A/S | 2008-11-01 |
| Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance (NCT00781937) | Novo Nordisk A/S | 2008-10-30 |
| Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin (NCT00775736) | Novo Nordisk A/S | 2008-10-01 |
| Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes (NCT00771680) | Novo Nordisk A/S | 2008-10-01 |
| To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo (NCT00761540) | Novo Nordisk A/S | 2008-10-01 |
| Observational Study on Safety of Self-titration of Once Daily Levemir® (NCT00740519) | Novo Nordisk A/S | 2008-09-01 |
| Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics (NCT00773279) | Novo Nordisk A/S | 2008-09-01 |
| Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months (NCT00755833) | Novo Nordisk A/S | 2008-09-01 |
| Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658 (NCT01529944) | Novo Nordisk A/S | 2008-09-01 |
| Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency (NCT00713648) | Novo Nordisk A/S | 2008-08-01 |
| Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 (NCT00722540) | Novo Nordisk A/S | 2008-07-01 |
| Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 (NCT00715689) | Novo Nordisk A/S | 2008-07-01 |
| Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics (NCT00697450) | Novo Nordisk A/S | 2008-07-01 |
| Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers (NCT00728455) | Novo Nordisk A/S | 2008-07-01 |
| A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide (NCT00696657) | Novo Nordisk A/S | 2008-06-03 |
| An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes (NCT00738153) | Novo Nordisk A/S | 2008-06-01 |
| Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes (NCT01464099) | Novo Nordisk A/S | 2008-06-01 |
| Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes (NCT00698802) | Novo Nordisk A/S | 2008-06-01 |
| Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes (NCT00699179) | Novo Nordisk A/S | 2008-06-01 |
| Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany (NCT00697320) | Novo Nordisk A/S | 2008-06-01 |
| Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents (NCT00715780) | Novo Nordisk A/S | 2008-06-01 |
| Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX (NCT00710619) | Novo Nordisk A/S | 2008-06-01 |
| The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus (NCT00700817) | Novo Nordisk A/S | 2008-06-01 |
| Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects (NCT02151409) | Novo Nordisk A/S | 2008-06-01 |
| Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects (NCT01868581) | Novo Nordisk A/S | 2008-05-01 |
| Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes (NCT00737776) | Novo Nordisk A/S | 2008-05-01 |
| Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (NCT00704223) | Novo Nordisk A/S | 2008-05-01 |
| Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding (NCT01561950) | Novo Nordisk A/S | 2008-05-01 |
| Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus (NCT00709475) | Novo Nordisk A/S | 2008-05-01 |
| Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30 (NCT00675493) | Novo Nordisk A/S | 2008-05-01 |
| Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen® (NCT00709683) | Novo Nordisk A/S | 2008-05-01 |
| Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes (NCT00687063) | Novo Nordisk A/S | 2008-04-01 |
| Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes (NCT00825643) | Novo Nordisk A/S | 2008-04-01 |
| Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment (NCT01076842) | Novo Nordisk A/S | 2008-04-01 |
| First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects (NCT01261767) | Novo Nordisk A/S | 2008-04-01 |
| Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes (NCT00696163) | Novo Nordisk A/S | 2008-04-01 |
| Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes (NCT01868568) | Novo Nordisk A/S | 2008-04-01 |
| Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes (NCT00735501) | Novo Nordisk A/S | 2008-03-01 |
| An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects (NCT00700648) | Novo Nordisk A/S | 2008-03-01 |
| Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors (NCT00703911) | Novo Nordisk A/S | 2008-03-01 |
| Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir) (NCT00657930) | Novo Nordisk A/S | 2008-03-01 |